A Simple and Effective Strategy for the Development of Robust Promoter-Centric Gene Expression Tools
Promoter-centric genetic tools play a crucial role in controlling gene expression for various applications, such as strain engineering and synthetic biology studies. Hence, a critical need persists for the development of robust gene expression tools. <i>Streptomyces</i> are well-known prolific producers of natural products and exceptional surrogate hosts for the production of high-value chemical compounds and enzymes. In this study, we reported a straightforward and effective strategy for the creation of potent gene expression tools. This was primarily achieved by introducing an additional -35-like motif upstream of the original -35 region of the promoter, coupled with the integration of a palindromic <i>cis</i>-element into the 5'-UTR region. This approach has generated a collection of robust constitutive and inducible gene expression tools tailored for <i>Streptomyces</i>. Of particular note, the fully activated <u>o</u>xytetracycline-inducible gene expression system containing an engineered <u><i>k</i></u><i>asO</i>p* promoter (<i>OK</i>) exhibited nearly an order of magnitude greater activity compared to the well-established high-strength promoter <i>kasO</i>p* under the tested conditions, establishing itself as a powerful gene expression system for <i>Streptomyces</i>. This strategy is expected to be applicable in modifying various other promoters to acquire robust gene expression tools, as evidenced by the enhancement observed in the other two promoters, <i>PL</i> and <i>P21</i> in this study. Moreover, the effectiveness of these tools has been demonstrated through the augmented production of transglutaminase and daptomycin. The gene expression tools established in this study, alongside those anticipated in forthcoming research, are positioned to markedly advance pathway engineering and synthetic biology investigations in <i>Streptomyces</i> and other microbial strains.
Authors
- Jay D. Keasling (ORCID: https://orcid.org/0000-0003-4170-6088)
- Xiaozhou Luo (ORCID: https://orcid.org/0000-0001-9808-6890)
- Tongjian Yang
- Guohui Pan (ORCID: https://orcid.org/0000-0002-8839-3886)
- Keqiang Fan (ORCID: https://orcid.org/0000-0003-2420-1889)
- Yihua Chen (ORCID: https://orcid.org/0000-0001-9362-512X)
Institutions
- Lawrence Berkeley National Laboratory (US)
- Chinese Academy of Sciences (CN)
- Novo Nordisk Foundation (DK)
- Microbiology Institute of Shaanxi (CN)
- Institute of Microbiology (CN)
- Shenzhen Institutes of Advanced Technology (CN)
- University of Chinese Academy of Sciences (CN)
- Joint BioEnergy Institute (US)
- University of California, Berkeley (US)
- Technical University of Denmark (DK)
Publication Details
- Journal
- ACS Synthetic Biology
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1021/acssynbio.4c00092
- Citations
- 2
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- Science and Technology Foundation of Shenzhen City
- National Natural Science Foundation of China
- National Key Research and Development Program of China